Highnoon Laboratories Limited (PSX: HINOON)
Pakistan
· Delayed Price · Currency is PKR 910.24
-9.16 (-1.00%)
At close: Dec 24, 2024
Highnoon Laboratories Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 23,023 | 19,766 | 15,816 | 13,001 | 10,698 | 9,048 | Upgrade
|
| Revenue Growth (YoY) | 22.13% | 24.98% | 21.65% | 21.53% | 18.24% | 20.59% | Upgrade
|
| Cost of Revenue | 11,381 | 10,368 | 7,625 | 6,475 | 5,455 | 4,815 | Upgrade
|
| Gross Profit | 11,642 | 9,398 | 8,190 | 6,526 | 5,243 | 4,232 | Upgrade
|
| Selling, General & Admin | 6,993 | 5,720 | 4,649 | 3,985 | 3,122 | 2,783 | Upgrade
|
| Research & Development | 22.13 | 15.02 | 10.63 | 8.67 | 6.38 | 5.01 | Upgrade
|
| Other Operating Expenses | 358.98 | 285.6 | 321.04 | 219.11 | 177.04 | 123.56 | Upgrade
|
| Operating Expenses | 7,374 | 6,020 | 4,981 | 4,213 | 3,306 | 2,912 | Upgrade
|
| Operating Income | 4,268 | 3,378 | 3,209 | 2,313 | 1,937 | 1,321 | Upgrade
|
| Interest Expense | -273.57 | -149.21 | -57.07 | -27.44 | -25.73 | -29.79 | Upgrade
|
| Interest & Investment Income | 290.66 | 99.43 | 233.75 | 132.59 | 60.74 | 51.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -48.4 | -46.41 | -7.15 | 2.52 | -8.36 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 49.17 | 45.33 | 38.79 | -2.42 | -1.57 | 3.25 | Upgrade
|
| EBT Excluding Unusual Items | 4,286 | 3,327 | 3,418 | 2,418 | 1,962 | 1,345 | Upgrade
|
| Gain (Loss) on Sale of Investments | 34.91 | 18.38 | 9.25 | 10.59 | 4.87 | 1.35 | Upgrade
|
| Gain (Loss) on Sale of Assets | 19.52 | 13.82 | 18.17 | 6.75 | 32.07 | 22.14 | Upgrade
|
| Pretax Income | 4,340 | 3,359 | 3,445 | 2,436 | 1,999 | 1,369 | Upgrade
|
| Income Tax Expense | 1,321 | 911.61 | 972.46 | 579.32 | 525.07 | 368.22 | Upgrade
|
| Earnings From Continuing Operations | 3,019 | 2,448 | 2,473 | 1,856 | 1,474 | 1,001 | Upgrade
|
| Net Income | 3,019 | 2,448 | 2,473 | 1,856 | 1,474 | 1,001 | Upgrade
|
| Net Income to Common | 3,019 | 2,448 | 2,473 | 1,856 | 1,474 | 1,001 | Upgrade
|
| Net Income Growth | 19.78% | -1.01% | 33.20% | 25.96% | 47.29% | 36.67% | Upgrade
|
| Shares Outstanding (Basic) | 53 | 53 | 53 | 53 | 53 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 53 | 53 | 53 | 53 | 53 | Upgrade
|
| Shares Change (YoY) | - | - | -0.00% | -0.00% | - | 0.00% | Upgrade
|
| EPS (Basic) | 56.98 | 46.20 | 46.67 | 35.04 | 27.82 | 18.89 | Upgrade
|
| EPS (Diluted) | 56.98 | 46.20 | 46.67 | 35.04 | 27.82 | 18.89 | Upgrade
|
| EPS Growth | 19.78% | -1.01% | 33.20% | 25.96% | 47.29% | 36.67% | Upgrade
|
| Free Cash Flow | 4,144 | 906.73 | -1,237 | 1,430 | 1,038 | 457.27 | Upgrade
|
| Free Cash Flow Per Share | 78.21 | 17.11 | -23.34 | 26.99 | 19.59 | 8.63 | Upgrade
|
| Dividend Per Share | 30.000 | 30.000 | 15.810 | 14.373 | 9.800 | 7.721 | Upgrade
|
| Dividend Growth | 89.75% | 89.75% | 10.00% | 46.67% | 26.92% | 10.00% | Upgrade
|
| Gross Margin | 50.57% | 47.55% | 51.79% | 50.20% | 49.01% | 46.78% | Upgrade
|
| Operating Margin | 18.54% | 17.09% | 20.29% | 17.79% | 18.11% | 14.60% | Upgrade
|
| Profit Margin | 13.11% | 12.38% | 15.63% | 14.28% | 13.78% | 11.06% | Upgrade
|
| Free Cash Flow Margin | 18.00% | 4.59% | -7.82% | 11.00% | 9.70% | 5.05% | Upgrade
|
| EBITDA | 4,518 | 3,576 | 3,392 | 2,480 | 2,066 | 1,435 | Upgrade
|
| EBITDA Margin | 19.62% | 18.09% | 21.45% | 19.08% | 19.31% | 15.86% | Upgrade
|
| D&A For EBITDA | 250.13 | 198.44 | 182.75 | 166.87 | 128.81 | 114.31 | Upgrade
|
| EBIT | 4,268 | 3,378 | 3,209 | 2,313 | 1,937 | 1,321 | Upgrade
|
| EBIT Margin | 18.54% | 17.09% | 20.29% | 17.79% | 18.11% | 14.60% | Upgrade
|
| Effective Tax Rate | 30.44% | 27.14% | 28.23% | 23.78% | 26.27% | 26.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.